Scalper1 News
Valeant Pharmaceuticals (VRX) late Wednesday said it has received subpoenas from U.S. Attorneys in Massachusetts and the Southern District of New York related to drug pricing and how it helps patients pay for drugs. It comes as Valeant and a slew of biotechs such as Biogen (BIIB), Gilead Sciences (GILD), Amgen (AMGN) and Celgene (CELG). Valeant said in a statement: “Most of the materials requested by the subpoenas relate to documents with respect Scalper1 News
Scalper1 News